GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study

Neurology

Volumn 75, Issue 20, 2010, Pages 1786-1793

  Vos, P E ^a   Jacobs, B ^a   Andriessen, T M J C ^a   Lamers, K J B ^b   Borm, G F ^a   Beems, T ^a   Edwards, M ^a   Rosmalen, C F ^b   Vissers, J L M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Future Diagnostics ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S100B;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMAN; HYPOTENSION; HYPOXIA; INJURY SEVERITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUPIL REFLEX; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INJURIES; COHORT STUDIES; DIAGNOSTIC TESTS, ROUTINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; S100 PROTEINS; YOUNG ADULT;

EID: 78650013269     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181fd62d2     Document Type: Article

References (40)

1. Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics. PLoS Med 2008;5:e165.
2. Perel P, Arango M, Clayton T, et al. Predicting outcome after traumatic brain injury: Practical prognostic models based on large cohort of international patients. BMJ 2008; 336:425-429.
3. Cremer OL, Moons KG, van Dijk GW, van BP, Kalkman CJ. Prognosis following severe head injury: Development and validation of a model for prediction of death, disability, and functional recovery. J Trauma 2006;61:1484-1491.
4. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT. Classification of traumatic brain injury for targeted therapies. J Neurotrauma 2008;25:719-738.
5. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. GFAP versus S100B in serum after traumatic brain injury: Relationship to brain damage and outcome. J Neurotrauma 2004;21:1553-1561.
6. Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J Neurosurg 2005;103:61-68.
7. Watt SE, Shores EA, Baguley IJ, Dorsch N, Fearnside MR. Protein S-100 and neuropsychological functioning following severe traumatic brain injury. Brain Inj 2006;20:1007-1017.
8. Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemela O, Hillbom M. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 2004;56:1229-1234.
9. Dimopoulou I, Korfias S, Dafni U, et al. Protein S-100b serum levels in trauma-induced brain death. Neurology 2003;60:947-951.
10. Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 2007;24: 1793-1801.
11. Shaw GJ, Jauch EC, Zemlan FP. Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med 2002;39:254-257.
12. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62:1303-1310.
13. Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use. J Neurotrauma 1998;15:573-585.
14. Vissers JL, Mersch ME, Rosmalen CF, et al. Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum. Clin Chim Acta 2006;366: 336-340.
15. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44:837-845.
16. Puri ML, Sen PK. Nonparametric Methods in Multivariate Analysis. Hoboken, NJ: Wiley; 1971.
17. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999;45:477-483.
18. Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: Results using a single (24h) timepoint. Resuscitation 2009;80:341-345.
19. Petzold A, Green AJ, Keir G, et al. Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: A pilot study. Crit Care Med 2002;30: 2705-2710.
20. Raabe A, Grolms C, Seifert V. Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg 1999;13:56-59.
21. Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 1999;47: 1126-1130.
22. Mussack T, Biberthaler P, Kanz KG, et al. Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit Care Med 2002;30: 2669-2674.
23. Nylen K, Ost M, Csajbok LZ, et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir 2008; 150:221-227.
24. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery 2001;48:1255-1258.
25. Pelinka LE, Toegel E, Mauritz W, Redl H. Serum S 100 B: A marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 2003;19:195-200.
26. Foerch C, Curdt I, Yan B, et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 2006;77:181-184.
27. Pelinka LE, Kroepfl A, Schmidhammer R, et al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma 2004;57:1006-1012.
28. Schafer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: Functions and pathology. Trends Biochem Sci 1996;21:134-140.
29. Woertgen C, Rothoerl RD, Brawanski A. Time profile of neuron specific enolase serum levels after experimental brain injury in rat. Acta Neurochir Suppl 2000;76:371-373.
30. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir 1997;139:1161-1164.
31. Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 2000;17:113-122.
32. Ergun R, Bostanci U, Akdemir G, et al. Prognostic value of serum neuron-specific enolase levels after head injury. Neurol Res 1998;20:418-420.
33. Ingebrigtsen T, Romner B, Marup-Jensen S, et al. The clinical value of serum S-100 protein measurements in minor head injury: A Scandinavian multicentre study. Brain Inj 2000;14:1047-1055.
34. Balestreri M, Czosnyka M, Chatfield DA, et al. Predictive value of Glasgow Coma Scale after brain trauma: Change in trend over the past ten years. J Neurol Neurosurg Psychiatry 2004;75:161-162.
35. Raabe A, Grolms C, Keller M, Dohnert J, Sorge O, Seifert V. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir 1998;140:787-791.
36. Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 1995;43:267-270.
37. Korfias S, Stranjalis G, Boviatsis E, et al. Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive Care Med 2007;33:255-260.
38. Nylen K, Ost M, Csajbok LZ, et al. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci 2006;240:85-91. (Pubitemid 41814959)
39. Zandbergen EG, Hijdra A, Koelman JH, et al. Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology 2006;66:62-68.
40. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter: Prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006;67:203-210.